Transcatheter Mitral valve procedure allows intervention on patients who are unsuitable or high risk for open heart surgery
LYNPARZA is approved in the U.S. for patients with HRR gene-mutated mCRPC (BRCA-mutated and other HRR gene mutations)
First and only FDA-approved device of its kind demonstrates consistently high rates of target limb salvage and freedom from clinically-driven target lesion revascularization
Plans to establish six state of the art TaCa Centre for Surgery in next 2 years in these states
The company exports mobile surgery equipment to over 100 countries from Pune
Novel approach driven by GN Corp Japan with potentials in neurological illnesses
At an affordable price, a researcher can process fresh samples of 10,000 cells immediately with a stable stopping point within two hours, simplifying sample management at the laboratory and limiting transcriptional changes
Cysoni is a bionic device that paces the heart with real-time respiratory modulation
The initial courses of Lap. Hernia Masterclass will encompass commonly performed hernia procedures
Subscribe To Our Newsletter & Stay Updated
